TY  - GEN
AU  - Müller,Norbert
AU  - Ulmschneider,Markus
AU  - Scheppach,Constanze
AU  - Schwarz,Markus J
AU  - Ackenheil,Manfred
AU  - Möller,Hans-Jürgen
AU  - Gruber,Rudolf
AU  - Riedel,Michael
TI  - COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy
SN  - 0940-1334
PY  - 2004///0506
KW  - Analysis of Variance
KW  - Antigens, CD
KW  - blood
KW  - Antipsychotic Agents
KW  - therapeutic use
KW  - Celecoxib
KW  - Cyclooxygenase Inhibitors
KW  - Cytokines
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Female
KW  - Flow Cytometry
KW  - methods
KW  - Humans
KW  - Male
KW  - Psychiatric Status Rating Scales
KW  - Pyrazoles
KW  - Receptors, Interleukin-2
KW  - Receptors, Tumor Necrosis Factor
KW  - Receptors, Tumor Necrosis Factor, Type I
KW  - Risperidone
KW  - Schizophrenia
KW  - drug therapy
KW  - Sulfonamides
KW  - T-Lymphocytes
KW  - drug effects
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1007/s00406-004-0478-1
ER  -